According to Mengke Pharmaceutical's announcement, the company's shareholder BestIdea plans to reduce its holdings by no more than 19.68,900 shares, accounting for 3% of the total share capital; shareholders JSR and GPTMT, acting as concerted actors, plan to reduce their holdings by no more than 19668,200 shares, accounting for 3% of the total share capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.